Header Logo

Connection

Alan Keller to Treatment Outcome

This is a "connection" page, showing publications Alan Keller has written about Treatment Outcome.
Connection Strength

0.027
  1. Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer. J Clin Oncol. 2010 Apr 10; 28(11):1835-42.
    View in: PubMed
    Score: 0.014
  2. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer. J Clin Oncol. 2009 Apr 20; 27(12):1941-7.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.